Apoptosis

Oncologist

Volumn 4, Issue 4, 1999, Pages 332-339

  Israels, Lyonel G ^a   Israels, Esther D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYANOCOBALAMIN; FOLIC ACID; IMMUNOGLOBULIN; IRON;

APOPTOSIS; CELL FUNCTION; COMPACT DISK; FOLATE METABOLISM; GENE CONTROL; HEMATOPOIESIS; MEDICAL INFORMATION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0032819967     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.4-4-332     Document Type: Review

References (33)

1. Allen PD, Bustin SA, Newland AC. The role of apoptosis (programmed cell death) in haemopoiesis and the immune system. Blood Rev 1993;7:63-73.
2. Alnemri ES. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J Cell Biochem 1997;64:33-42.
3. Berke G. The CTL's kiss of death. Cell 1995;81:9-12.
4. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993;341:1251-1254.
5. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-130.
6. Collins MK, Rivas AL. The control of apoptosis in mammalian cells. Trends Biochem Sci 1993;18:307-309.
7. Grana X, Garriga J, Mayol X. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell death. Oncogene 1998;17:3365-3383.
8. Green DG, Reed JL. Mitochondria and apoptosis. Science 1998;281:1309-1312.
9. Kasten MM, Giordano A. pRb and the Cdks in apoptosis and the cell cycle. Cell Death Differ. 1998;5:132-140.
10. Korsmeyer SJ. Bcl-2: an antidote to programmed cell death. Cancer Surv 1992;15:105-118.
11. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:44-51.
12. Kumar S. The Bcl-2 family of proteins and activation of ICE-CED-3 family of proteases: a balancing act in apoptosis? Cell Death Differ 1997;4:2-3.
13. LaCasse EC, Baird S, Korneluk RG et al. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998;17:3247-3259.
14. Le Deist F, Emile JF, Rieux-Laucat F et al. Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet 1996;348:719-723.
15. Liu C-C, Walsh CM, Young JD-E. Perform: structure and function. Immunol Today 1995;16:194-201.
16. Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol 1994;57:129-144.
17. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-1456.
18. Nunez G, Benedict MA, Hu Y et al. Caspases: the proteases of the apoptotic pathway. Oncogene 1998;17:3237-3245.
19. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 1994;79:189-192.
20. Prives C. Signaling by p53: breaking the MDM2-p53 circuit. Cell 1998;95:5-8.
21. Raff M. Cell suicide for beginners. Nature 1998;396:119-122.
22. Reed JC. Cytochrome C: can't live with it; can't live without it. Cell 1997;91:559-562.
23. Reed JC. Bd-2 family proteins. Oncogene 1998;17:3225-3236.
24. Rudin CM, Thompson CB. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med 1997;48:267-281.
25. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997;91:443-446.
26. Smyth MJ, Trapani JA. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995;16:202-206.
27. Squier MKT, Sehnert AJ, Cohen JJ. Apoptosis in leukocytes. J Leukoc Biol 1995;57:2-10.
28. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-1449.
29. Straus SE (moderator). An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med 1999;130:591-601.
30. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
31. Thornberry NA, Lazebnik. Caspases: enemies within. Science 1998;281:1312-1316.
32. Ueda N, Shah SV. Apoptosis. J Lab Clin Med 1994;124:169-177.
33. Wyllie AH. Apoptosis. Br J Cancer 1993;67:205-208.